Mirati Therapeutics appoints Chris LeMasters as Chief Business Officer
Mirati Therapeutics announced the appointment of Chris LeMasters to the newly created position of Executive Vice President and Chief Business Officer, effective September 30. Prior to joining Mirati, LeMasters served as the CEO of Promosome, a privately held biotherapeutics and biosimilars company. Previously, LeMasters held senior management positions at several biotherapeutics companies, most recently as co-founder and chief business officer of Tragara Pharmaceuticals, a clinical-stage cancer therapeutics company. LeMasters also served as co-founder and chief business officer of Cabrellis Pharmaceuticals, where he negotiated its acquisition by Pharmion for $104M, and as vice president, corporate development of Conforma Therapeutics, where he negotiated its acquisition by Biogen IDEC for $250M.